Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › GENERAL PROVISIONS › Section 441A.200 - List of adopted recommendations, guidelines and publications; review of revision or amendment of adopted recommendation, guideline or publication

Current through June 11, 2024
1. Except as otherwise provided in subsection
			 2, the following recommendations, guidelines and publications are adopted by
			 reference:
(a) The standard precautions to
			 prevent transmission of disease by contact with blood or other body fluids as
			 recommended by the Centers for Disease Control and Prevention in "Perspectives
			 in Disease Prevention and Health Promotion Update: Universal Precautions for
			 Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus,
			 and Other Bloodborne Pathogens in Health-Care Settings,"
Morbidity and
			 Mortality Weekly Report
[37(24):377-388, June 24, 1988], published by
			 the United States Department of Health and Human Services and available at no
			 cost on the Internet at
http://www.cdc.gov/mmwr
, or, if that
			 Internet website ceases to exist, from the Division.
(b) The Centers for Disease Control and
			 Prevention's
2007 Guideline for Isolation Precautions: Preventing
			 Transmission of Infectious Agents in Healthcare Settings
, published by
			 the United States Department of Health and Human Services and available at no
			 cost on the Internet at
https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines-H.pdf
,
			 or, if that Internet website ceases to exist, from the Division.
(c) The recommended guidelines for the
			 investigation, prevention, suppression and control of communicable disease set
			 forth by the Centers for Disease Control and Prevention in:
(1) "General Recommendations on Immunization:
			 Recommendations of the Advisory Committee on Immunization Practices,"
Morbidity and Mortality Weekly Report
[55(RR15):1- 48,
			 December 1, 2006], published by the United States Department of Health and
			 Human Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division; and
(2)
Manual for the Surveillance of
			 Vaccine-Preventable Diseases
, published by the United States
			 Department of Health and Human Services and available at no cost on the
			 Internet at
http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
,
			 or, if that Internet website ceases to exist, from the Division.
(d) The recommended guidelines for
			 the investigation, prevention, suppression and control of communicable diseases
			 contained in
Control of Communicable Diseases Manual
, 21st
			 edition, published by the American Public Health Association and available for
			 the price of $59.50 for members and
			 $85.00 for nonmembers from the
			 American Public Health Association, 800 I Street, N.W., Washington, D.C.
			 20001-3710, or at the Internet address
http://www.apha.org
.
(e) The recommended guidelines for the
			 investigation, prevention, suppression and control of communicable diseases
			 contained in
Red Book: 2021 Report of the Committee on Infectious
			 Diseases
, 32nd edition, published by the American Academy of
			 Pediatrics and available for the price of $119.95 for members and
			 $149.95 for nonmembers from the
			 American Academy of Pediatrics, 345 Park Boulevard, Itasca, Illinois 60143, or
			 at the Internet address
https://shop.aap.org
.
(f) The recommendations for the testing,
			 treatment, prevention, suppression and control of chancroid,
Chlamydia
			 trachomatis
, gonococcal infection, granuloma inguinale,
			 lymphogranuloma venereum, infectious syphilis and human immunodeficiency virus
			 as are specified in "Sexually Transmitted Infections Treatment Guidelines,
			 2021,"
Morbidity and Mortality Weekly Report
[70(4):1-187,
			 July 23, 2021], published by the United States Department of Health and Human
			 Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division.
(g) The recommendations for the counseling of
			 and effective treatment for a person having active tuberculosis or tuberculosis
			 infection as set forth in:
(1) Controlling
			 Tuberculosis in the United States: Recommendations from the American Thoracic
			 Society, CDC, and the Infectious Diseases Society of America,"
Morbidity and Mortality Weekly Report
[54(RR12):1-81, November
			 4, 2005], published by the United States Department of Health and Human
			 Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division;
(2) "Treatment of Tuberculosis,"
Morbidity and Mortality Weekly Report
[52(RR11):1-77, June 20,
			 2003], published by the United States Department of Health and Human Services
			 and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division;
(3) "Targeted Tuberculin Testing and
			 Treatment of Latent Tuberculosis Infection,"
Morbidity and Mortality
			 Weekly Report
[49(RR06):1-54, June 9, 2000], published by the United
			 States Department of Health and Human Services and available at no cost on the
			 Internet at
http://www.cdc.gov/mmwr
, or, if that
			 Internet website ceases to exist, from the Division;
(4) The recommendations of the Centers for
			 Disease Control and Prevention for preventing and controlling tuberculosis in
			 correctional and detention facilities set forth in "Prevention and Control of
			 Tuberculosis in Correctional and Detention Facilities: Recommendations from
			 CDC,"
Morbidity and Mortality Weekly Report
[55(RR09):1-44,
			 July 7, 2006], published by the United States Department of Health and Human
			 Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division; and
(5) Guidelines for the Investigation of
			 Contacts of Persons with Infectious Tuberculosis: Recommendations from the
			 National Tuberculosis Controllers Association and CDC,"
Morbidity and
			 Mortality Weekly Report
[54(RR15):1-37, December 16, 2005], published
			 by the United States Department of Health and Human Services and available at
			 no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if that
			 Internet website ceases to exist, from the Division.
(h) The recommendations of the Centers for
			 Disease Control and Prevention for preventing the transmission of tuberculosis
			 in facilities providing health care set forth in "Guidelines for Preventing the
			 Transmission of
Mycobacterium tuberculosis
in Health-Care
			 Settings, 2005,"
Morbidity and Mortality Weekly Report
[54(RR17):1-141, December 30, 2005], published by the United States Department
			 of Health and Human Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division.
(i) "Case Definitions for Infectious
			 Conditions Under Public Health Surveillance,"
Morbidity and Mortality
			 Weekly Report
[46(RR10):1-55, May 2, 1997], published by the United
			 States Department of Health and Human Services and available at no cost on the
			 Internet at
http://www.cdc.gov/mmwr
, or, if that
			 Internet website ceases to exist, from the Division.
(j) "Recommended Antimicrobial Agents for
			 Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines,"
Morbidity and Mortality Weekly Report
[54(RR14):1-16, December
			 9, 2005], published by the United States Department of Health and Human
			 Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division.
(k) "Updated Recommendations for Isolation of
			 Persons with Mumps,"
Morbidity and Mortality Weekly Report
[57(40):1103-1105, October 10, 2008], published by the United States Department
			 of Health and Human Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division.
(l) "Recommendations for Partner Services
			 Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection,"
Morbidity and Mortality Weekly Report
[57(RR09):1-83, November
			 7, 2008], published by the United States Department of Health and Human
			 Services and available at no cost on the Internet at
http://www.cdc.gov/mmwr
, or, if
			 that Internet website ceases to exist, from the Division.
(m) "Facility Guidance for Control of
			 Carbapenem-resistant
Enterobacteriaceae
(CRE)," published by
			 the United States Department of Health and Human Services and available at no
			 cost from the Centers for Disease Control and Prevention on the Internet at
https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf
,
			 or, if that Internet website ceases to exist, from the Division.
(n) "Interim Guidance for a Public Health
			 Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs),"
			 published by the United States Department of Health and Human Services and
			 available at no cost from the Centers for Disease Control and Prevention on the
			 Internet at
https://www.cdc.gov/hai/pdfs/containment/Health-Response-Contain-MDRO-H.pdf
,
			 or, if that Internet website ceases to exist, from the Division.
(o) The guidelines for the prevention,
			 postexposure management and control of rabies as specified in the "Compendium
			 of Animal Rabies Prevention and Control, 2016," published by the National
			 Association of State Public Health Veterinarians and available at no cost on
			 the Internet at
http://nasphv.org/documentsCompendiaRabies.html
,
			 or, if that Internet website ceases to exist, from the Division.
(p) "Carbapenemase Producing
			 Carbapenem-Resistant Enterobacteriaceae (CP-CRE) 2018 Case Definition,"
			 published by the United States Department of Health and Human Services and
			 available at no cost on the Internet at
https://ndc.services.cdc.gov/case-definitions/carbapenemase-producing-carbapenem-resistant-enterobacteriaceae-2018/
,
			 or, if that Internet website ceases to exist, from the Division.
(q) The recommendations for offering
			 culturally and linguistically appropriate services set forth in "National
			 Standards for Culturally and Linguistically Appropriate Services (CLAS) in
			 Health and Health Care," published by the United States Department of Health
			 and Human Services and available at no cost on the Internet at
https://thinkculturalhealth.hhs.gov/clas
,
			 or, if that Internet website ceases to exist, from the Division.
(r) "Human Immunodeficiency Virus (HIV)
			 Infection: Screening," published by the United States Preventive Services Task
			 Force and available at no cost on the Internet at
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
,
			 or, if that Internet website ceases to exist, from the Division.
(s) "Syphilis Infection in Nonpregnant
			 Adolescents and Adults: Screening," published by the United States Preventive
			 Services Task Force and available at no cost on the Internet at
https://uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-nonpregnant-adults-adolescents-screening
,
			 or, if that Internet website ceases to exist, from the Division.
(t) "Chlamydia and Gonorrhea: Screening,"
			 published by the United States Preventive Services Task Force and available at
			 no cost on the Internet at
https://uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening
,
			 or, if that Internet website ceases to exist, from the Division.